Opthea Limited (OPT.AX)
AUD 0.6
(0.0%)
AUD 0.6
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -30.82 Million USD | 76.95% |
| 2023 | -133.71 Million USD | -106.02% |
| 2022 | -64.9 Million USD | 58.73% |
| 2021 | -157.28 Million USD | -154.69% |
| 2020 | -61.75 Million AUD | -186.77% |
| 2019 | -21.53 Million AUD | 33.76% |
| 2018 | -32.51 Million AUD | 37.43% |
| 2017 | -51.95 Million AUD | -258.68% |
| 2016 | -14.48 Million AUD | -2.45% |
| 2015 | -14.14 Million AUD | -109.7% |
| 2014 | -6.74 Million AUD | 32.85% |
| 2013 | -10.04 Million AUD | 40.31% |
| 2012 | -16.82 Million AUD | 28.79% |
| 2011 | -23.62 Million AUD | 12.74% |
| 2010 | -27.07 Million AUD | 13.62% |
| 2009 | -31.34 Million AUD | 29.12% |
| 2008 | -44.21 Million AUD | -8.17% |
| 2007 | -40.87 Million AUD | -277.11% |
| 2006 | -10.83 Million AUD | 27.76% |
| 2005 | -15 Million AUD | -23.13% |
| 2004 | -12.18 Million AUD | -23.2% |
| 2003 | -9.89 Million AUD | 12.17% |
| 2002 | -11.26 Million AUD | 13.15% |
| 2001 | -12.96 Million AUD | -4622.38% |
| 2000 | -274.6 Thousand AUD | 99.75% |
| 1999 | -109.6 Million AUD | -127550.5% |
| 1998 | -85.86 Thousand AUD | 17.67% |
| 1997 | -104.29 Thousand AUD | -13352.38% |
| 1996 | 786.99 AUD | 102.01% |
| 1995 | -39.06 Thousand AUD | -24.32% |
| 1994 | -31.42 Thousand AUD | 95.37% |
| 1993 | -679.33 Thousand AUD | -35.91% |
| 1992 | -499.83 Thousand AUD | -159.88% |
| 1991 | -192.33 Thousand AUD | -3941.26% |
| 1990 | -4759.19 AUD | 81.46% |
| 1989 | -25.67 Thousand AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -156.93 Million USD | 0.0% |
| 2024 FY | -30.82 Million USD | 76.95% |
| 2024 Q4 | -30.82 Million USD | 0.0% |
| 2023 FY | -133.71 Million USD | -106.02% |
| 2023 Q4 | -133.71 Million USD | 0.0% |
| 2023 Q2 | -79.01 Million USD | 0.0% |
| 2022 FY | -64.9 Million USD | 58.73% |
| 2022 Q2 | -121.32 Million USD | 0.0% |
| 2022 Q4 | -44.63 Million USD | 0.0% |
| 2021 Q2 | -202.33 Million USD | 0.0% |
| 2021 Q4 | -118.08 Million USD | 0.0% |
| 2021 FY | -157.28 Million USD | -154.69% |
| 2020 FY | -61.75 Million AUD | -186.77% |
| 2020 Q4 | -61.75 Million AUD | 0.0% |
| 2020 Q2 | -74.7 Million AUD | 0.0% |
| 2019 Q2 | -40.14 Million AUD | 0.0% |
| 2019 Q4 | -21.53 Million AUD | 0.0% |
| 2019 FY | -21.53 Million AUD | 33.76% |
| 2018 Q4 | -32.51 Million AUD | 0.0% |
| 2018 FY | -32.51 Million AUD | 37.43% |
| 2017 Q4 | -39.92 Million AUD | 0.0% |
| 2017 FY | -51.95 Million AUD | -258.68% |
| 2016 FY | -14.48 Million AUD | -2.45% |
| 2016 Q4 | -10.81 Million AUD | 0.0% |
| 2015 FY | -14.14 Million AUD | -109.7% |
| 2015 Q4 | -14.14 Million AUD | 0.0% |
| 2014 FY | -6.74 Million AUD | 32.85% |
| 2014 Q4 | -6.74 Million AUD | 0.0% |
| 2013 Q4 | -10.04 Million AUD | 0.0% |
| 2013 FY | -10.04 Million AUD | 40.31% |
| 2012 Q4 | -16.82 Million AUD | 0.0% |
| 2012 FY | -16.82 Million AUD | 28.79% |
| 2011 FY | -23.62 Million AUD | 12.74% |
| 2011 Q4 | -23.62 Million AUD | 0.0% |
| 2010 Q4 | -27.07 Million AUD | 0.0% |
| 2010 FY | -27.07 Million AUD | 13.62% |
| 2009 FY | -31.34 Million AUD | 29.12% |
| 2009 Q4 | -31.34 Million AUD | 0.0% |
| 2008 FY | -44.21 Million AUD | -8.17% |
| 2008 Q4 | -44.21 Million AUD | 0.0% |
| 2007 Q4 | -40.87 Million AUD | 0.0% |
| 2007 FY | -40.87 Million AUD | -277.11% |
| 2006 FY | -10.83 Million AUD | 27.76% |
| 2006 Q4 | -10.83 Million AUD | 0.0% |
| 2005 FY | -15 Million AUD | -23.13% |
| 2005 Q4 | -15 Million AUD | 0.0% |
| 2004 Q4 | -12.18 Million AUD | 0.0% |
| 2004 FY | -12.18 Million AUD | -23.2% |
| 2003 Q4 | -9.89 Million AUD | 0.0% |
| 2003 FY | -9.89 Million AUD | 12.17% |
| 2002 FY | -11.26 Million AUD | 13.15% |
| 2002 Q4 | -11.26 Million AUD | 0.0% |
| 2001 FY | -12.96 Million AUD | -4622.38% |
| 2001 Q4 | -12.96 Million AUD | 0.0% |
| 2000 FY | -274.6 Thousand AUD | 99.75% |
| 2000 Q4 | -274.6 Thousand AUD | 0.0% |
| 1999 FY | -109.6 Million AUD | -127550.5% |
| 1999 Q4 | -73.16 Thousand AUD | 0.0% |
| 1998 FY | -85.86 Thousand AUD | 17.67% |
| 1997 Q4 | -78.59 Thousand AUD | 0.0% |
| 1997 FY | -104.29 Thousand AUD | -13352.38% |
| 1996 FY | 786.99 AUD | 102.01% |
| 1995 FY | -39.06 Thousand AUD | -24.32% |
| 1994 FY | -31.42 Thousand AUD | 95.37% |
| 1993 FY | -679.33 Thousand AUD | -35.91% |
| 1992 FY | -499.83 Thousand AUD | -159.88% |
| 1991 FY | -192.33 Thousand AUD | -3941.26% |
| 1990 FY | -4759.19 AUD | 81.46% |
| 1989 FY | -25.67 Thousand AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AdAlta Limited | -845.17 Thousand AUD | -3547.024% |
| Acrux Limited | -1.45 Million AUD | -2014.106% |
| Alterity Therapeutics Limited | -12.47 Million AUD | -146.988% |
| Biome Australia Limited | -1.56 Million AUD | -1872.327% |
| Biotron Limited | -386.06 Thousand AUD | -7883.998% |
| Botanix Pharmaceuticals Limited | -79.3 Million AUD | 61.134% |
| BTC Health Limited | -2.02 Million AUD | -1424.298% |
| Chimeric Therapeutics Limited | -3.05 Million AUD | -909.618% |
| Clinuvel Pharmaceuticals Limited | -182.98 Million AUD | 83.155% |
| Immutep Limited | -122.18 Million AUD | 74.774% |
| Memphasys Limited | 4.13 Million AUD | 845.366% |
| Noxopharm Limited | -2.31 Million AUD | -1228.648% |
| Prescient Therapeutics Limited | -10.16 Million AUD | -203.302% |
| Race Oncology Limited | -17.18 Million AUD | -79.324% |
| Radiopharm Theranostics Limited | -18.57 Million AUD | -65.941% |
| Tissue Repair Ltd | -16.44 Million AUD | -87.48% |
| EZZ Life Science Holdings Limited | -18.89 Million AUD | -63.099% |
| Anatara Lifesciences Ltd | -982.1 Thousand AUD | -3038.524% |
| Bio-Gene Technology Limited | -709.55 Thousand AUD | -4244.065% |
| Zelira Therapeutics Limited | 5.06 Million AUD | 708.282% |
| Patrys Limited | -2.24 Million AUD | -1275.65% |
| Orthocell Limited | -19.92 Million AUD | -54.7% |
| Imugene Limited | -91.56 Million AUD | 66.335% |
| PYC Therapeutics Limited | -65.76 Million AUD | 53.128% |
| Proteomics International Laboratories Limited | -6.32 Million AUD | -387.419% |
| Cynata Therapeutics Limited | -6.2 Million AUD | -396.722% |
| CSL Limited | 15.76 Billion AUD | 100.196% |
| Arovella Therapeutics Limited | -12.71 Million AUD | -142.431% |
| Clarity Pharmaceuticals Ltd | -136.5 Million AUD | 77.42% |
| Starpharma Holdings Limited | -19.83 Million AUD | -55.424% |
| Nanollose Limited | -96.22 Thousand AUD | -31932.902% |
| Invex Therapeutics Ltd | -6.02 Million AUD | -411.59% |
| NeuroScientific Biopharmaceuticals Limited | -4.95 Million AUD | -522.18% |
| Amplia Therapeutics Limited | -1.82 Million AUD | -1590.273% |
| Island Pharmaceuticals Limited | -1.23 Million AUD | -2388.973% |
| Nyrada Inc. | -4.76 Million AUD | -546.283% |
| Telix Pharmaceuticals Limited | -105.79 Million AUD | 70.864% |
| Dimerix Limited | -21.99 Million AUD | -40.16% |
| Neuren Pharmaceuticals Limited | -17.09 Million AUD | -80.319% |
| PharmAust Limited | -9.71 Million AUD | -217.308% |
| Hexima Limited | -2.22 Million AUD | -1284.578% |
| AnteoTech Limited | -5 Million AUD | -516.285% |
| Paradigm Biopharmaceuticals Limited | -17.58 Million AUD | -75.319% |
| Recce Pharmaceuticals Ltd | -3.39 Million AUD | -807.61% |
| Avecho Biotechnology Limited | -5.32 Million AUD | -478.387% |
| Actinogen Medical Limited | -9.13 Million AUD | -237.547% |
| Immuron Limited | -11.48 Million AUD | -168.41% |
| Argenica Therapeutics Limited | -15.91 Million AUD | -93.705% |